One of the world’s largest businesses serving the life sciences, BD Biosciences provides tools and reagents to study life–from normal processes to disease states–and to accelerate the pace of biomedical discovery. Throughout the world, clinicians and researchers use BD Biosciences’ tools to study genes, proteins and cells to better understand disease, improve diagnosis and disease management, and facilitate the discovery and development of novel therapeutics.

     The primary markets served by BD Biosciences are research and clinical laboratories; hospitals and transplant centers; blood banks; and biotechnology and pharmaceutical companies.

     BD Biosciences’ principal product lines include fluorescence activated cell sorters and analyzers; monoclonal antibodies and kits; reagent systems for life sciences research; tools to aid in drug discovery and growth of tissue cells; molecular biology products for the study of genes; and diagnostic assays.

Organized into two principal units–Preanalytical Systems and Diagnostic Systems–BD Diagnostics offers system solutions for collecting, identifying and transporting specimens; advanced instrumentation for quickly and accurately analyzing specimens; and services focused on customers’ process flow, supply chain management and training and education.

     BD Diagnostics serves the following markets: hospitals, laboratories and clinics; reference laboratories; blood banks; healthcare workers; patients; physicians’ office practices; and industrial microbiology laboratories.

     BD Diagnostics’ principal products and services are integrated systems for evacuated blood collection; safety-engineered specimen collection products and systems; plated media; automated blood culturing and molecular testing systems; microorganism identification and drug susceptibility systems; medication error and specimen management systems; and healthcare consulting and services.

BD Medical holds leadership positions in hypodermic needles and syringes, infusion therapy devices, insulin injection systems, and prefillable drug delivery systems for pharmaceutical companies. It offers the industry’s broadest, deepest line of safety-engineered sharps products, as well as surgical and regional anesthesia, ophthalmology, critical care, medication management and sharps disposal products.

     The primary markets served by BD Medical are hospitals and clinics; physicians’ office practices; consumers and retail pharmacies; public health agencies; and pharmaceutical companies.

     BD Medical’s principal product lines include needles and syringes for medication delivery; IV catheters and infusion therapy products; surgical blades and regional anesthesia products; ophthalmic surgical products; safety-engineered injection, infusion and surgery devices; sharps disposal containers; insulin delivery devices and blood glucose monitors; and home healthcare products.